The Musculoskeletal Tumor Society Clinical Practice Guideline on the Management of Metastatic Humeral Disease.

J Am Acad Orthop Surg · May 15 2024 · Review

Tedesco NS, Mesko N, Wodajo F, Management of Metastatic Humeral Disease Work Group, Staff of the American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society, Management of Metastatic Humeral Disease Work Group and Staff of the American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society

From the Department of Orthopaedic Surgery, Western University College of Osteopathic Medicine of the Pacific…

Orthopaedic Oncology

SUMMARY — THE REDUCTIONThis AAOS-endorsed guideline offers seven evidence-based recommendations for surgical management of metastatic, myeloma, and lymphoma disease of the humerus.
Abstract, as published

Management of Metastatic Humeral Disease is based on a systematic review of published studies surrounding the management of metastatic disease, multiple myeloma, and lymphoma limited to the humerus. This guideline contains seven action statements to assist orthopaedic surgeons, orthopaedic oncologists, physicians, and any other qualified healthcare professionals involved in the surgical management of metastatic disease of the humerus. It is also intended to serve as an information resource for decision makers, researchers, and developers of clinical practice guidelines. In addition to providing pragmatic practice recommendations, this guideline also highlights gaps in the literature and informs areas for future research and quality measure development. This guideline has been endorsed by the American Academy of Orthopaedic Surgeons.

Featured in the 2026-07-28 issue.

← Endoprosthetic Reconstruction of the Upper Extremity in Oncol…Metastatic bone disease: Pathogenesis and therapeutic options →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.